The biotechnology market experiences substantial growth, driven by innovative technologies and underscored by notable advancements in molecular diagnostics. Therefore, investors could consider investing in top biotech stocks Equillium, Inc. (EQ), United Therapeutics Corporation (UTHR), and Vertex Pharmaceuticals Incorporated (VRTX) for weekly end-of-year profits.
The global pharmaceutical manufacturing sector's growth is further fueled by a shift toward single-use disposable solutions, smart operations, and a focus on personalized medicine, prompting a restructuring of supply chains to align with patient-centric healthcare models. The market is expected to grow at a CAGR of 7.6% from 2023 to 2030.
